跳至主要内容
临床试验/NCT05112302
NCT05112302Enrolling By Invitation不适用

Use of Virtual Reality as an Adjunct for Anesthesia During Orthopedic Procedures Under Regional or Central Neuraxial Nerve Block. A Pilot and Feasibility Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2021年8月17日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Mayo Clinic
入组人数
50
试验地点
1
主要终点
Impact of virtual reality on anxiety level

研究概览

简要总结

The purpose of this study is to obtain feedback from patients and orthopedic surgeons who agree to use virtual reality (VR ) as an adjunct to standard of care in orthopedic cases under regional or central neuraxial nerve block. This will serve as a preliminary study for future trials to compare outcomes between VR and standard of care vs standard of care only.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old.
  • Patients scheduled for orthopedic procedure under regional or central neuraxial nerve block (anterior primary hip arthroplasty or primary knee arthroplasty).
  • Subject willing to participate and able to provide informed consent.

排除标准

  • Age < 18 years old.
  • History of motion sickness or blindness.
  • Unable to consent due to cognitive difficulty.
  • Current diagnosis of epilepsy, dementia, or other neurological disease that may prevent use of VR hardware and software.
  • Sensitivity to flashing light or motion.
  • Recent stroke.
  • Injury to the eyes, face, neck, or arms that prevents comfortable use of VR hardware or software, or safe use of the hardware (e.g., open wound, sores, or skin rash on face).

结局指标

主要结局

Impact of virtual reality on anxiety level

时间窗: Up to 2 hours

Evaluate patients' satisfaction with using virutal reality and reduction in anxiety during orthopedic procedures

次要结局

  • Impact of virtual reality on patient's perioperative temperature(Up to 3 hours)
  • Impact of virtual reality on pharmacological therapy doses(Up to 2 hours)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Klaus D. Torp

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验